ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,921.30
0.76%
S&P ASX All Technology
3,078.20
0.32%
Brent Oil
79.745
0.00%
US Dollar vs AUD
1.52742
-0.09%
Bitcoin
67,874.82
-0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Xeris Biopharma Holdings Inc (XERS) Share Price

Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

NASDAQ
2.61
0.055
(2.15%)
At close: 27 July 6:00AM
Delayed by 15 minutes
2.62
0.01
( 0.38% )
After Hours: 8:56AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.62
Bid
2.58
Offer
2.64
Volume
1,234,708
2.54 Day's Range 2.64
1.46 52 Week Range 3.26
Market Cap
388.43M
Previous Close
2.555
Open
2.59
Last Trade
360
@
2.62
(formt)
Last Trade Time
Financial Volume
US$ 3,209,239
VWAP
2.5992
Average Volume (3m)
1,326,051
Shares Outstanding
148,255,663
Dividend Yield
-
PE Ratio
-6.19
Earnings Per Share (EPS)
-0.42
Revenue
163.91M
Net Profit
-62.26M

About Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.xerispharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was US$2.56. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 1.46 to US$ 3.26.

Xeris Biopharma currently has 148,255,663 shares in issue. The market capitalisation of Xeris Biopharma is US$378.79 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -6.19.

XERS Latest News

More News

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

25 July 2024
Business Wire

Form 8-K - Current report

08 July 2024
Edgar (US Regulatory)

Xeris Biopharma Announces CEO Succession Plan

John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director Transition timing aligns with the solid financial position of the Company, including...

08 July 2024
Business Wire

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

04 July 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

06 June 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 June 2024
Edgar (US Regulatory)

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

In patients with Cushing’s syndrome maintained on Recorlev, a lower baseline mUFC was associated with higher cortisol normalization rate. Lower mUFC at baseline was also associated with lower...

03 June 2024
Business Wire

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

XeriSol™ formulation enabled predictable bioavailability and sustained levels of levothyroxine in a once-weekly subcutaneous presentation Once-weekly SC levothyroxine (XP-8121) participants...

30 May 2024
Business Wire
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10.239.623430962342.392.642.3310193472.48175442CS
40.3816.96428571432.242.642.0311411212.35115567CS
120.7237.89473684211.92.641.7213260512.18666416CS
260.166.504065040652.463.261.6915998052.3586654CS
520.218.713692946062.413.261.4615177972.26828522CS
156-0.71-21.32132132133.333.4050.970116882122.24243597CS
260-9.63-78.61224489812.2512.50390.970117011663.13322112CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VPRVolt Group Ltd
AUD 0.002
(100.00%)
12.5k
KNBOKoonenberry gold Ltd
AUD 0.004
(100.00%)
260.57k
WOAOWide Open Agriculture Ltd
AUD 0.003
(50.00%)
1M
MCTMetalicity Ltd
AUD 0.003
(50.00%)
1.33M
INDIndustrial Minerals Limited
AUD 0.255
(41.67%)
151.45k
ESROBEstrella Resources Limited
AUD 0.001
(-50.00%)
2M
FG1OFlynn Gold Limited
AUD 0.004
(-42.86%)
2.02M
OVTOvanti Ltd
AUD 0.003
(-40.00%)
6.24M
CPOOCulpeo Minerals Ltd
AUD 0.008
(-33.33%)
400k
IMIInfinity Mining Ltd
AUD 0.01
(-28.57%)
232.1k
BGLBellevue Gold Limited
AUD 1.45
(-20.98%)
80.17M
E79E79 Gold Mines Ltd
AUD 0.041
(20.59%)
56.75M
AGYArgosy Minerals Inc
AUD 0.049
(40.00%)
53.8M
JRVJervois Global Ltd
AUD 0.016
(6.67%)
42.87M
REDRed 5 Limited
AUD 0.375
(-5.06%)
36.66M

XERS Discussion

View Posts
Pascal2 Pascal2 2 weeks ago
We need to rebound to 3 first. Back to level. Normal And to 4. Is possible ..
👍️0
Monksdream Monksdream 4 months ago
XERS under $3
👍️0
StocksNcash StocksNcash 4 months ago
Still here👍
👍️0
Frankestin Frankestin 5 months ago
We are ready?🙏
👍️0
Nadendla Nadendla 5 months ago
ya..:)
👍️0
StocksNcash StocksNcash 5 months ago
Your welcome
👍️0
buccaneer1961 buccaneer1961 5 months ago
Thankyou!
👍️0
StocksNcash StocksNcash 5 months ago
Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
XERS...3.29 BREAK OUT COMING UP
👍️0
buccaneer1961 buccaneer1961 5 months ago
Green lately..whats the catalysts?
👍️0
StocksNcash StocksNcash 5 months ago
Buy hold and don’t look back$$$$$
👍️0
Monksdream Monksdream 5 months ago
XERS new 52 week high
👍️0
Rkrocks Rkrocks 1 year ago
Let’s hope to break 3.00 soon
👍️0
price_and_volume price_and_volume 2 years ago
Izzy Englander likes $XERS...

https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
👍️0
mess124 mess124 3 years ago
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

Strongbridge vanished and XERS showed up.


Thank you
👍️0
Elgordo84 Elgordo84 3 years ago
Yes indeed
👍️0
alchemytrader alchemytrader 3 years ago
Nice catch in the low 2.00s.
👍️0
Elgordo84 Elgordo84 3 years ago
Goodluck to all the Longs!
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Ramping up for sure.
👍️0
Elgordo84 Elgordo84 3 years ago
I like what I see here!

Looks like a Trend reversal

Great with patience!

Let’s go $XERS

#EG84
👍️0
ahimsa27 ahimsa27 3 years ago
PDUFA New Years ?
👍️0
$Money Bags$ $Money Bags$ 3 years ago
They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
👍️0
ezyE ezyE 3 years ago
Can we make it rain here?
👍️0
kzivann kzivann 3 years ago
Premarket action .. nice news.


XERS
👍️0
tknuncle tknuncle 3 years ago
Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

https://www.otcmarkets.com/stock/SLS/security

Thanks for any feed back. Much appreciated
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [ X ].
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
👍️0
Modlich Modlich 3 years ago
Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Nom nom nom bring the gains.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
👍️0
harr449 harr449 3 years ago
Recent announcement of deal caused PT to go from $14 to $9.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
You guys enjoying the start of this nice run?
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Delicious.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
👍️0
I Dump I Dump 3 years ago
Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Conversions on this are still brutal. Float is low, one day she breaks the chains.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Good news out after hours. $$$
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
👍️0
mte1955 mte1955 3 years ago
My thoughts exactly. Hopefully the dance continues for this and many other stocks.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
👍️0
Termite7 Termite7 3 years ago
Good chart!!!
👍️0
trustbutverifyit trustbutverifyit 4 years ago
Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
👍️0
Cpops Cpops 4 years ago
The secret is out!
👍️0
TFMG TFMG 4 years ago




$XERS | #Xeris Pharma On Breakout Watch



Alert set for a break above the 200ma and $5.00 level.
Highly speculative with high Risk| Reward .
Company profile
Xeris Pharmaceuticals , Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.


PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.






👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... GTFOH ... $XERS

EPIC LOSSES
NO CORONA AND LIME
BEER MONEY TRAPPED FOREVER

$XERS went public at 15 only 2 years ago. While 7 looks good to someone buying at 3, there's a lot of investors who'd be taking a loss at 7. The ultra bull case is $XERS gets up to the mid teens organically and then gets a buyout for a big premium in the mid 20s

#ROFLMFAO #EatLOSSES

👍️0

Your Recent History

NASDAQ
XERS
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved